Tomorrow Will Be Insane
6 extracted signals · 6 resolved · 0 still active
StockedUpIndependent analyst profile- Source published
- 28 May 2026, 21:59 UTC
- Recorded by Tahlil Plus
- 30 Jul 2026, 04:31 UTC
AI-generated source summary
The analysis focuses on several US stocks showing bullish momentum. SPY is nearing all-time highs at $755.28, with a target of $756.50 and a fail bound at $753.84. UMAC is also showing strength, trading at $29.06 with a target of $31.99 and a fail bound at $25.12. ONDS is bullish at $13.11 targeting $13.50 with a fail bound at $12.01. RCAT is on the rise at $14.15, aiming for $15.00 with a fail bound at $12.81. KTOS shows strong upward momentum at $65.75, targeting $67.00 with a fail bound at $61.44. Finally, MSFT is showing a strong recovery and is approaching a critical resistance zone around $432.99-$434.50; a break above this could target $450.00 with a failure point at $420.99. The overall market sentiment appears positive for these tech and industrial stocks, with several showing strong upward trends and potential for continued gains.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
6 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
StockedUp
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.